Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naim Alkhouri

Showing results (11-20 of 306) with videos related to

Pageof 31
Sort By:
Hepatobiliary Surgery and Nutrition|January 10, 2018
Nonalcoholic fatty liver disease and hepatocellular carcinoma: new insights on presentation and natural historyDanny Issa, Naim Alkhouri
Clinical Liver Disease|August 13, 2021
Artificial Intelligence in Nonalcoholic Fatty Liver Disease: A New Frontier in Diagnosis and TreatmentPankaj Aggarwal, Naim Alkhouri
Expert Opinion on Investigational Drugs|January 20, 2021
A perspective on RNA interference-based therapeutics for metabolic liver diseasesNaim Alkhouri, Samer Gawrieh
Med (New York, N.Y.)|June 12, 2026
Therapeutic development in MASH: From accelerated approval to cirrhosis trial innovationWinston Dunn, Naim Alkhouri
Current Gastroenterology Reports|July 22, 2025
Resmetirom for Steatotic Liver Disease: Does Data Support Widespread Use?Winston Dunn, Naim Alkhouri
Hepatology (Baltimore, Md.)|March 31, 2012
The TONIC trial: a step forward in treating pediatric nonalcoholic fatty liver diseaseNaim Alkhouri, Ariel E Feldstein
Cleveland Clinic Journal of Medicine|March 3, 2012
Protease inhibitors: silver bullets for chronic hepatitis C infection?Naim Alkhouri, Nizar N Zein
Current Opinion in Pediatrics|June 22, 2016
Three-dimensional printing and pediatric liver diseaseNaim Alkhouri, Nizar N Zein
Metabolism: Clinical and Experimental|March 15, 2016
Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?Naim Alkhouri, Ariel E Feldstein
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 23, 2025
MASLD in Patients With Chronic Hepatitis B Virus Infection: Hiding in Plain SightNaim Alkhouri, Jean-Michel Pawlotsky
Pageof 31

Showing results (11-20 of 306) with videos related to

Sort By:
Pageof 31
Hepatobiliary Surgery and Nutrition|January 10, 2018
Nonalcoholic fatty liver disease and hepatocellular carcinoma: new insights on presentation and natural historyDanny Issa, Naim Alkhouri
Clinical Liver Disease|August 13, 2021
Artificial Intelligence in Nonalcoholic Fatty Liver Disease: A New Frontier in Diagnosis and TreatmentPankaj Aggarwal, Naim Alkhouri
Expert Opinion on Investigational Drugs|January 20, 2021
A perspective on RNA interference-based therapeutics for metabolic liver diseasesNaim Alkhouri, Samer Gawrieh
Med (New York, N.Y.)|June 12, 2026
Therapeutic development in MASH: From accelerated approval to cirrhosis trial innovationWinston Dunn, Naim Alkhouri
Current Gastroenterology Reports|July 22, 2025
Resmetirom for Steatotic Liver Disease: Does Data Support Widespread Use?Winston Dunn, Naim Alkhouri
Hepatology (Baltimore, Md.)|March 31, 2012
The TONIC trial: a step forward in treating pediatric nonalcoholic fatty liver diseaseNaim Alkhouri, Ariel E Feldstein
Cleveland Clinic Journal of Medicine|March 3, 2012
Protease inhibitors: silver bullets for chronic hepatitis C infection?Naim Alkhouri, Nizar N Zein
Current Opinion in Pediatrics|June 22, 2016
Three-dimensional printing and pediatric liver diseaseNaim Alkhouri, Nizar N Zein
Metabolism: Clinical and Experimental|March 15, 2016
Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?Naim Alkhouri, Ariel E Feldstein
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 23, 2025
MASLD in Patients With Chronic Hepatitis B Virus Infection: Hiding in Plain SightNaim Alkhouri, Jean-Michel Pawlotsky
Pageof 31